TM
QTTB icon

Tiger Management’s Q32 Bio QTTB Stock Holding History

Tiger Management’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,319
Closed -$531K – 28
2018
Q4 		$531K Buy
+1,319
New +$499K 0.13% 27

Other funds holding QTTB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VM
VV Manager Boston, Massachusetts $114M AUM 59.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Tiger Management's QTTB Position: Q1 2019 in Review

Tiger Management sold out of Q32 Bio (QTTB) in Q1 2019, closing a stake of 1,319 shares — an estimated $531K sold.

Tiger Management first reported a position in QTTB in Q4 2018 and held it in 1 quarter. The position peaked at $531K in Q4 2018. 66 funds tracked by Wall St. Rank hold QTTB as of Q1 2019.

  • Tiger Management reported no remaining Q32 Bio position as of Q1 2019 after selling out during the quarter.
  • Tiger Management sold 1,319 Q32 Bio shares in Q1 2019, an estimated $531K.
  • Tiger Management first reported a position in Q32 Bio in Q4 2018 and held it in 1 quarter.
  • Tiger Management's Q32 Bio position peaked at $531K in Q4 2018.
  • 66 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2019.

Based on Tiger Management's 13F filing for Q1 2019, filed 15 May 2019.